The BalancedInvestor Club

PAHC Market Analysis

Overview

Fundamentals

P/E ratio24.29Forward 13.83
EPS (TTM)$2.26752.0% YoY
Profit margin6.3%HEALTHCARE
Market cap$2.22BMid cap

Wall Street coverage

$51.20median target· current $16.45 (+211.2%)4 analysts

Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.

Valuation

Forward P/E
13.83
PEG ratio
1.68
P/B
6.69
P/S (TTM)
1.52
EV/EBITDA
13.50

Profitability & growth

ROE (TTM)
31.8%
Operating margin
14.7%
Revenue growth YoY
20.9%
Dividend yield
0.9%
Beta
0.69
Last earnings
Feb 4, 2026 · Estimate $0.68 · Reported $0.87
Analyst estimate. Actual results often differ.

Ratios are point-in-time. Historical metrics — no guarantees about what comes next.

News & Sentiment

Page 1 of 3 · 50 total

Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.

About Phibro Animal Health Corporation

Phibro Animal Health Corporation develops, manufactures and supplies a range of mineral nutrition and animal health products for livestock primarily in the United States. The company is headquartered in Teaneck, New Jersey.

Classification

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
Country
USA
Currency
USD

Company profile

HQ
GLENPOINTE CENTRE EAST, TEANECK, NJ
Fiscal year end
June
Latest quarter
Dec 31, 2025
Market cap$2.22B
Shares outstanding$20.6M
52W high$60.08
52W low$18.64

Educational content · Not investment advice or recommendations

We're educators, not advisors. Your decisions are your own. Disclaimer